tetrabenazine has been researched along with Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albin, RL; Bohnen, NI; Davatzikos, C; Foerster, BR; Frey, KA; Herman, WH; Hsieh, M; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M | 1 |
1 other study(ies) available for tetrabenazine and Atrophy
Article | Year |
---|---|
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
Topics: Aged; Atrophy; Attention; Basal Ganglia; Brain Diseases; Carbon Radioisotopes; Case-Control Studies; Cognition; Cross-Sectional Studies; Diabetes Complications; Dopaminergic Neurons; Executive Function; Female; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2016 |